Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared a post on X:
“Our analysis of intensive chemotherapy (IC) in CBF-AML (200 pt) is out in eJHaem Journal! Kudos to lead author Alexandra Rojek.
We found:
-similar EFS/OS between IC + GO and IC alone
-longer 3y EFS with IC + KIT inhibitor (85%)
We eagerly await NCT02013648 results!
A huge thanks to co-authors Yasmin Abaza, Charlie Foucar, Rory M. Shallis, Talha Badar and those not on twitter!“
Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia
Autors: Alexandra E. Rojek, Benjamin J. McCormick, Joanna Cwykiel, Oluwatobi Odetola, Yasmin Abaza, Nhi Nai, Charles E. Foucar, Rohan K. Achar, Rory M. Shallis, Danielle Bradshaw, Meaghan Standridge, Vamsi Kota, Guru Subramanian Guru Murthy, Talha Badar, Anand A. Patel.
Source: Anand Patel/X
